British American Tobacco plc Heading For 9% Growth

Forecasts indicate a return to earnings growth for British American Tobacco plc (LON: BATS)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Earnings growth at British American Tobacco (LSE: BATS) (NYSE: BTI.US) has been sliding over the past five years. Back in 2009, the purveyor of the deadly weed enjoyed a 19% rise in earnings per share (EPS), but since then the annual rise has slowed as far as last year’s 5% — and there’s a small fall of 1% forecast for the year to December 2014.

british american tobacco / imperial tobaccoDividend growth has been slowing too, from the days of 14% growth in 2010 to 5.6% in 2013, although that is not expected to turn negative along with earnings. In fact, there’s still a dividend boost of 3.8% forecast for this year, to take the payout to 147p and provide a yield of 4.3% on a 3,464p share price.

2015 reversal

And expectations for 2015 are currently indicating a reversal of recent fortunes — we have a 9% EPS rise penciled in, together with a 7% hike in the dividend to take the yield up to 4.6%.

These predictions are way down on the analysts’ positions 12 months ago, mind — back then the consensus suggested EPS of 251p for 2014 with a dividend of 164p, and it’s a big drop to the latest 215p and 147p respectively.

Share price picking up

The share price has been falling for much of the past year too, and early in 2014 it had dropped around 20% — but we’ve since seen a recovery to take us back to a modest 5% slip over 12 months.

The problems for the tobacco business are well known — people are simply smoking less, and stick volumes at British American and rival Imperial Tobacco have been steadily falling year-on-year. But a switch in focus towards premium-priced brands has helped keep earnings rising, albeit at a slower pace.

Surprisingly popular

That, the healthy nature of the dividends (if not the companies’ products), coupled with the largely defensive nature of the business as an investment, has helped keep the punters bullish on British American shares.

In fact, out of a sample of 23 analysts, 13 rate the shares a Buy or a Strong Buy, with only two thinking we should sell the shares — the remaining eight are sticking with a Hold stance.

Not for the long term

Are the commentators right and should we buy British American Tobacco? Well, the City does tend to have a short-term outlook, and with a forward P/E of 16 for this year dropping to 14.5 for 2015, the shares are not overvalued in the short term.

But if you have a 10 or 20-year horizon, there are surely better places for your investment cash than a declining industry.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan does not own any shares in British American Tobacco.

More on Investing Articles

Young female business analyst looking at a graph chart while working from home
Investing Articles

Is Avon Protection the best stock to buy in the FTSE All-Share index right now?

Here’s a stock I’m holding for recovery and growth from the FTSE All-Share index. Can it be crowned as the…

Read more »

Investing Articles

Down 8.5% this month, is the Aviva share price too attractive to ignore?

It’s time to look into Aviva and the insurance sector while the share price is pulling back from year-to-date highs.

Read more »

Investing Articles

Here’s where I see Vodafone’s share price ending 2024

Valued at just twice its earnings, is the Vodafone share price a bargain or value trap? Our writer explores where…

Read more »

Businesswoman analyses profitability of working company with digital virtual screen
Investing Articles

The Darktrace share price jumped 20% today. Here’s why!

After the Darktrace share price leapt by a fifth in early trading, our writer explains why -- and what it…

Read more »

Dividend Shares

850 shares in this dividend giant could make me £1.1k in passive income

Jon Smith flags up one dividend stock for passive income that has outperformed its sector over the course of the…

Read more »

Investing Articles

Unilever shares are flying! Time to buy at a 21% ‘discount’?

Unilever shares have been racing higher this week after a one-two punch of news from the company. Here’s whether I…

Read more »

artificial intelligence investing algorithms
Market Movers

The Microsoft share price surges after results. Is this the best AI stock to buy?

Jon Smith flags up the jump in the Microsoft share price after the latest results showed strong demand for AI…

Read more »

Google office headquarters
Investing Articles

A dividend announcement sends the Alphabet share price soaring. Here’s what investors need to know

As the Alphabet share price surges on the announcement of a dividend, Stephen Wright outlines what investors should really be…

Read more »